Today, a group of AngelMD network investors is proud to announce its investment into HeartHero. HeartHero is a Denver-based company that has developed a smaller and lighter automated external defibrillator (AED) to increase the survivability of sudden cardiac arrest (SCA). The AngelMD syndicate has invested over $500,000 into HeartHero’s oversubscribed Series A round of funding.
SCA claims over 350,000 lives each year in the United States alone. For every minute that an SCA patient goes untreated, their survival chances drop by up to ten percent. AED intervention dramatically increases the patient’s chances of survival, but AEDs are widely unavailable outside of a hospital or professional setting.
“AngelMD’s investment and physician network is proof that a better outcome is wanted for Cardiac Arrest”, said HeartHero CEO Gary Montague. “They have been pivotal in helping us increase our reach with partners and opening doors to accelerate our company to save lives sooner. These connections would have otherwise been challenging to make, and for this, we couldn’t ask for a better partner.”
At half the size and weight of AEDs currently on the market and using standard consumer batteries, the HeartHero AED can be carried easily or stored at home by people at an increased risk of sudden cardiac arrest or their family. The HeartHero device guides the user through the resuscitation process with CPR prompts along with an auditory and visual guide.
“The portability and affordability of the HeartHero AED will save lives. By decreasing the time to life-saving defibrillation is how Elliot will improve the outcomes of sudden cardiac arrest,” said Dr. Bill Quirk, emergency room physician and HeartHero Chief Medical Officer. “We believe death from SCA is preventable. Our AED will empower family members and good samaritans to treat the #1 cause of death in the USA. The Resuscitation Revolution is here. HeartHero is excited to develop and deploy key tools in the chain of survival with our partners at AngelMD. Together we will save lives.”
The AngelMD syndicate investment follows HeartHero’s recent string of successes. The company was named as the winner of the American College of Cardiology’s Innovation Challenge pitch competition, as well as the American College of Emergency Physicians innovatED Innovation Challenge.
AngelMD, an online Healthcare Investment and Innovation Marketplace, connects and engages a network of physicians, angel investors, early stage healthcare companies and subject matter experts through a powerful technology platform to create better outcomes for patients and investors.
For more information, visit http://www.angelmd.co
HeartHero is working to increase survival rates by closing the gap between sudden cardiac arrest (SCA) and when an ambulance arrives. The company is addressing this public health crisis by building a portable, affordable automated external defibrillator (AED). By making AEDs more accessible and creating a connected ecosystem, HeartHero is empowering anyone, anywhere to save a life.
Learn more at www.hearthero.com
Company Name: AngelmD
Contact Person: Brad McCarty
Email: Send Email
Address:3513 Brighton Blvd, Suite 300
Country: United States